In this issue, Odetola et al.1 detail a convincing case of immune-mediated thrombotic thrombocytopenic purpura (iTTP) in the setting of pregnancy treated successfully by the anti-von Willebrand factor (vWF) caplacizumab. iTTP is caused by autoantibodies directed against the vWF-cleaving protein ADAMTS13. The ensuing severe ADAMTS13 deficiency results in the accumulation of plasma ultra-large vWF multimers that induce disseminated microvascular platelet clumping with organ damage.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Paul
Contact Paul, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack